Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Moderate to Severe Hidradenitis Suppurativa
NCT00827996Phase 2Completed
- Sponsor
- Florida Academic Dermatology Centers
- Start
- Feb 2007
- Primary completion
- Nov 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of adalimumab in hidradenitis suppurativa (HS), sponsored by Florida Academic Dermatology Centers. Started Feb 2007; status: completed.
02
Drugs
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT00827996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827996.